Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Total Liabilities (2024 - 2026)

Updated

Curanex Pharmaceuticals (CURX) posted Total Liabilities of $286,254 for Q2 2026, down 40.6% from $481,743 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals' Total Liabilities came in at $361,040.

  • In prior years, Curanex Pharmaceuticals' Total Liabilities was $14,575 in FY2024.
  • Quarterly Total Liabilities has run from a low of $14,575 in Q4 2024 to a high of $481,743 in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 116.09 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 141.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 65.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 37.53 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 115.64 Bn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn - 286,254.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 286,254.00
Dec 31, 2025 361,040.00
Sep 30, 2025 185,955.00
Jun 30, 2025 481,743.00
Dec 31, 2024 14,575.00
API Access

Curanex Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=CURX&period=max&api_key=YOUR_API_KEY